Related Experiment Video
Updated: Sep 8, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Endovascular treatment of intracranial aneurysms using the Derivo Embolization Device: a multicenter experience
Galileu Chagas Lourenço1, François Dantas2, Tiago Silva E Carvalho2
1Department of Interventional Neuroradiology, Biocor Instituto, Nova Lima, Minas Gerais, Brazil galileucl@gmail.com.
Insights
The Derivo Embolization Device is a safe and effective treatment for intracranial aneurysms, showing high occlusion rates and minimal adverse events in a 1-year follow-up study.
Area of Science:
- Neurosurgery
- Interventional Neuroradiology
- Vascular Neurology
Background:
- Flow diversion is a primary treatment for various intracranial aneurysms.
- The Derivo Embolization Device is utilized for treating these aneurysms.
- A 1-year angiographic follow-up was conducted for patients treated with this device.
Purpose of the Study:
- To evaluate the clinical and angiographic outcomes of intracranial aneurysm treatment using the Derivo Flow Diverter.
- To determine the complete aneurysm occlusion rate at 12 months post-treatment.
- To assess the incidence of serious adverse events associated with the device.
Main Methods:
- Multicenter retrospective analysis of prospectively collected data.
- Evaluation of complete aneurysm occlusion using digital subtraction angiography (DSA).
- Logistic regression analyses were performed to identify predictors of outcomes.
Main Results:
- The study included 127 patients with 177 intracranial aneurysms across three centers.
- Total occlusion rate at 12 months was 83.3%, with a favorable occlusion rate of 97.7%.
- 97.6% of patients experienced no serious adverse events, and no procedure-related mortality occurred.
Conclusions:
- The Derivo Embolization Device demonstrates significant safety and efficacy in treating intracranial aneurysms.
- High rates of total and favorable occlusion were achieved within 1 year.
- The device is associated with minor morbidity and no intervention-related mortality.
Background:
Flow diversion is the first-line treatment for several types of intracranial aneurysms. We report on a large series of patients treated with the Derivo Embolization Device who underwent a 1-year angiographic control follow-up.
Methods:
We performed a multicenter retrospective analysis of prospectively collected data, designed to evaluate the clinical and angiographic results of treatment of intracranial aneurysms with the Derivo Flow Diverter. The primary endpoint was complete occlusion of the aneurysm within 12 months, which was evaluated using DSA. The secondary endpoint was the absence of any serious adverse events. Univariate and multivariate logistic regression analyses were performed to analyze the data.
Results:
The study was conducted from December 2016 to September 2019 and enrolled 127 patients with 177 intracranial aneurysms, treated at three different centers. Efficacy at 6 months was 70.1% (122/174) for total occlusion and 87.3% (152/174) for favorable occlusion and, at 12 months, it was 83.3% (145/174) for total occlusion and 97.7% (170/174) for favorable occlusion. Regarding safety concerns, 97.6% (124/127) of patients did not experience severe adverse effects during the follow-up period of 12 months, and there was no procedure-related mortality.
Conclusions:
The Derivo Embolization Device, achieving a total occlusion rate of 83.3% and a favorable occlusion rate of 97.7% in a 1-year angiographic control study of 174 aneurysms with minor morbidity and no intervention-related mortality, is a safe and effective treatment for intracranial aneurysms.
More Related Videos
07:21Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
Published on: September 8, 2023
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Aneurysm III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Aneurysm IV: Nursing Management